Initially identified in gastric cancer, FER1L4 has since been reported to be an oncogene by modulating the PI3K/AKT pathway in various cancer cells, including osteosarcoma, hepatocellular carcinoma, and colon cancer. Here, FER1L4 is linked to hepatocellular carcinoma.